Position
Parallel Advisors, LLC in Cytokinetics Inc
Back to the book · All holders of CYTK
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.98K$63.54 → $65.91
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 834 | $53K | — | — | — | 0.0% |
| Q1 2026 | 919 | $60.6K | $65.91 | $1.98K | $5.6K | 0.0% |